Will weight loss injections get cheaper in the UK?

The real reason prices rose instead of falling

If you've been watching this space, you'll have noticed the direction of travel hasn't been downward. Eli Lilly raised Mounjaro's UK list price from around £122 to around £330 per four-week pen at the highest dose, effective September 2025, a change widely reported at the time. That was a manufacturer decision, and it pushed private prices up across the board rather than down. Wegovy has followed its own trajectory, with the introduction of a higher 7.2mg dose in 2026 creating new pricing tiers rather than reducing existing ones.

The forces keeping prices elevated are structural. Both tirzepatide and semaglutide remain under patent. Manufacturing capacity, although expanded, has not created the kind of surplus that typically pushes consumer prices lower. And demand for these medicines remains strong, which removes the competitive pressure that might otherwise force prices down. The current landscape for weight loss injections in the UK reflects all of this: a market where supply and demand still favour the manufacturers.

That said, nothing is permanent. Patent expiry, the arrival of biosimilar versions, and increased NHS uptake could all shift the dynamic over the next several years. If you're wondering whether weight loss injections will get cheaper in the coming years, projecting timelines is speculative, but it would be reasonable to expect that a broader NHS rollout gradually reduces the private market, and that longer-term pricing moves when biosimilars eventually enter. The honest answer for someone deciding now is that a meaningful fall within the next 12 to 18 months is not a safe assumption to plan around.

What a headline price often leaves out

One reason price comparisons across providers are harder than they look: the number you see first rarely includes everything you'll actually pay. Some providers charge separately for the consultation, the prescription, delivery, or aftercare. A lower headline figure can turn out to be higher in practice once those are added. It's worth spending sixty seconds on any provider's checkout page before assuming you know what you're comparing, the full cost only becomes clear when you reach the summary.

Clinical oversight matters here too. These are prescription-only medicines, which means a prescriber must assess your medical history, current medication and any contraindications before approving treatment. A service that bundles that properly (including re-review before every repeat order, not just at sign-up) is doing something more substantive than one that treats the prescription as a formality. The consultation process at nume covers all of this at no extra charge.

NICE's appraisal of tirzepatide (TA1026, published December 2024) and its earlier recommendation for semaglutide (Wegovy) both set out clear eligibility criteria, BMI thresholds, qualifying comorbidities, and review points. A prescriber working to those standards is doing a materially different job to one rubber-stamping requests. That difference has a cost, and it belongs in any honest price comparison.

Where the NHS fits in, and why it doesn't resolve the decision now

NHS access to tirzepatide is being phased in gradually. From June 2025, adults with a BMI of 40 or above and four or more specific weight-related conditions became eligible. Cohort 2, covering BMI 35 to 39.9 with the same conditions, activated in June 2026. Further cohorts are expected around March 2027. The full pathway is described on our page about NHS access and what it currently covers.

For the majority of people asking whether injections will become cheaper, the NHS route is either not yet available to them or involves waiting lists that run to months. That's not a criticism of the NHS, it's a phased rollout of a genuinely limited resource. But it does mean that for many people, the practical decision is a private one, made now, with private pricing as it stands. If you want to understand what the cheapest weight loss injection options currently look like, NHS expansion may reduce the private market over time, but it doesn't resolve a decision you're facing today.

Scotland, Wales and Northern Ireland have their own devolved criteria and timelines, which our FAQs page addresses briefly. If you're outside England, the NHS picture may differ.

Why the cheapest listing isn't the right question to ask

For most purchases, the lowest price signals good value. For a prescription medicine, it signals something different: either a genuine introductory offer (possible, not guaranteed to last) or a supplier who has cut corners somewhere in the clinical process, the supply chain, or both.

The MHRA has been explicit about the risk. In October 2025, a raid in Northampton uncovered the UK's first illicit manufacturing site producing counterfeit tirzepatide pens, following earlier seizures totalling around 20 million doses of illegally traded weight loss medicines with an estimated street value of £45m. Fake pens have contained insulin, a potentially life-threatening substance in someone without diabetes. If you're exploring where to find cheaper weight loss injections without compromising on safety, our page covers how to check whether a pharmacy is legitimate using the GPhC register in about thirty seconds, a step worth taking before ordering anywhere.

At nume, one price covers the consultation, prescription, medicine, next-working-day tracked delivery and priority aftercare seven days a week. There's no subscription, no auto-renewal, and no charges added at the end. We're a GPhC-registered pharmacy, you can verify that directly at our entry on the GPhC register (number 9012878). We don't compete on price because that's not a race we chose to enter. What we can offer is speed, genuine clinical oversight, and a supply chain you can trace. If you'd like to understand what makes a genuinely cheap weight loss injection worth considering, our page walks through the factors that separate a fair price from a false economy. More about how we work is on our about page. To see whether you're eligible, the place to start is your free consultation.